Catalog No. B1045

Sunitinib

(别名:舒尼替尼

RTK抑制剂

Sunitinib
规格价格货期数量
1mL(10 mM in DMSO)
¥500.00
现货
100mg
¥454.00
现货
200mg
¥666.00
现货
500mg
¥909.00
现货
1g
¥1363.00
现货
2g
¥1818.00
现货
CAS号:557795-19-4纯度:97.47%
仅用于科研,不用于诊疗。未经明确授权不得转售。
A
021-55669583sales@apexbio.cnAPExBIO

特色产品

Annexin V-FITC/PI Apoptosis Kit
Annexin V-FITC/PI Apoptosis Kit
用于双染检测细胞凋亡和坏死
- 在10-20分钟内完成染色
- 适用于流式细胞仪和荧光显微镜检测
- 准确区分活细胞/凋亡细胞/坏死细胞
Phos binding reagent (Phosbind) acrylamide
Phos binding reagent (Phosbind) acrylamide
分离和检测磷酸化/非磷酸化蛋白
- 新型的磷酸盐结合标签和功能分子
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8)
用于细胞增殖和细胞毒性试验
- 比MTT,MTS或WST-1更敏感
- 对细胞无毒性
- 步骤更简单,无需有机溶剂
Cy5 TSA Fluorescence System Kit
Cy5 TSA Fluorescence System Kit
Cy5荧光标记的酪胺信号放大系统
- 检测ICC/IHC/ISH中的低丰度靶点
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
用于观察mRNA运送,定位,翻译
- 具有Cap1结构的荧光素酶mRNA
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
HotStart™ 2X Green qPCR Master Mix
HotStart™ 2X Green qPCR Master Mix
用于荧光定量目标DNA或cDNA
- 通过热启动机制优化扩增特异性
- 优异的扩增效率、可重复性和稳定性
- 卓越的灵敏度和准确性,操作简单
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit Plus
高效的Cy5修饰RNA转录试剂盒
- 适合原位/Northernblot杂交实验
- 优化的缓冲液和T7 RNA聚合酶混合物
- 20 μL反应体系可获得更高的RNA产量

产品描述

舒尼替尼(CAS 557795-19-4)是一种口服生物利用度小分子抑制剂,可靶向多种受体酪氨酸激酶(RTKs),包括血管内皮生长因子受体1-3(VEGFR1-3)、血小板衍生生长因子受体α/β(PDGFRα/β)、c-kit及RET。研究表明,舒尼替尼可抑制鼻咽癌细胞系HK1、CNE-1、CNE-2、HONE-1和C666-1的增殖,其半数抑制浓度(IC50)值约为2.06至7.57微摩尔(μM)。此外,它还能诱导鼻咽癌细胞系凋亡和G0/G1期细胞周期阻滞,并在体内CNE-2异种移植肿瘤模型中显著降低微血管密度。因此,舒尼替尼可用于研究肿瘤血管生成和增殖相关通路。

参考文献:

[1]Hui EP1, Lui VW, Wong CS, Ma BB, Lau CP, Cheung CS, Ho K, Cheng SH, Ng MH, Chan AT. Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma. Invest New Drugs. 2011 Dec;29(6):1123-31.

产品性质

物理外观A solid
CAS号557795-19-4
分子式C22H27FN4O2
分子量398.47
化学名称N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
溶解度insoluble in H2O; ≥19.9 mg/mL in DMSO with gentle warming; ≥3.16 mg/mL in EtOH with gentle warming
SMILESCCN(CC)CCNC(c1c(C)[nH]c(C=C(c(cc(cc2)F)c2N2)C2=O)c1C)=O
存储条件-20°C
运输条件蓝冰

产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)

IC50和靶点

生物活性描述Sunitinib是一种可口服的多靶点受体酪氨酸激酶(RTK)小分子抑制剂。
靶点VEGFR-2PDGFRαPDGFRβc-Kit
生物活性数据4 nM69 nM39 nM1-10 nM

生物相关数据

质量控制

请选择批次查看:
纯度 = 97.47%

操作说明

APExBIO 顾客使用本产品发表的 11 篇科研文献

1. Zixuan Chen, Yu Zhang, et al. "Gingerenone A inhibits LDHA-mediated glycolysis and restores sunitinib sensitivity in renal cell carcinoma." Biochem Pharmacol. 2025 Nov 26:117563. PMID: 41314434

2. Zixuan Chen, Weiyuan Li, et al. "Chrysin enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis via targeting PI3K/Akt/GPX4 pathway." Toxicol Appl Pharmacol. 2025 Aug 21:117531. PMID: 40848919

3. Zixuan Chen, Xing Jia, et al. "A novel peptide TCL6148 induces ferroptosis via the GOT1/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma." Int J Biol Macromol. 2025 Jun:313:144242. PMID: 40379184

4. Zixuan Chen, Chengtao Han, et al. "2‐Undecanone induces ferroptosis via the STAT3/GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib." Biofactors. 2025 Mar-Apr;51(2):e70016. PMID: 40200786

5. Ângela Marques-Magalhães, Filipa Moreira-Silva, et al. "Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma." Front Oncol. 2025 Mar 24;15:1399956. PMID: 40196736

6. Nicole A Muench, Heather M Schmitt, et al. "Preservation of Murine Whole Eyes With Supplemented UW Cold Storage Solution: Anatomical Considerations." Transl Vis Sci Technol. 2024 Nov 4;13(11):24. PMID: 39560629

7. Zixuan Chen, Xing Jia, et al. "AUY922 Improves Sensitivity to Sunitinib in Clear Cell Renal Cell Carcinoma Based on Network Pharmacology and in Vitro Experiments." Heliyon. 2024 Jul 18;10(14):e34834. PMID: 39149033

8. Zixuan Chen, Sheng Cheng, et al. "Syringin as a novel therapeutic agent for renal cell carcinoma by targeting EGFR/PI3K/Akt pathway and enhancing sunitinib efficacy." Journal of Functional Foods Volume 123, December 2024, 106556

9. Marieke Van Daele, Laura E Kilpatrick, et al. "Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET." Biochem Pharmacol. 2023 Aug;214:115672. PMID: 37406966

10. Jia-Qi Guo, Chang-Dong Wang, et al. "PDGF‐BB/PDGFRβ Promotes Epithelial‐Mesenchymal Transition by Affecting PI3K/AKT/mTOR‐Driven Aerobic Glycolysis in Wilms' tumor G401 Cells." Cell Biol Int. 2022 Feb 14. PMID: 35165984

11. Bhola PD, Ahmed E, et al. "High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors." Sci Signal. 2020;13(636):eaay1451. PMID: 32546544

摩尔浓度计算器

质量
= 浓度
x 体积
x 分子量
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Apexbio的产品页面获得)批次特异的分子量使用本工具。
产品目录
产品目录
质量认证
产品目录
联系我们
通讯
获取最新资讯,产品折扣和优惠。
Copyright ©2013-2026 APExBIO Technology. All Rights Reserved.沪公网安备 31011002003500沪公网安备 31011002003500沪ICP备14019579号-3